Irving Franco, M.D.

Irving Franco, MD, is an interventional cardiologist in the Cleveland Clinic Department of Interventional Cardiology. In his work as an interventional cardiologist, Dr. Franco’s specialty interests include diagnostic cardiac catheterization, angiography, coronary angioplasty, acute coronary interventions, coronary atherectomy, rotational coronary stenting and laser therapy.

A native of the Dominican Republic and a naturalized U.S. citizen, Dr. Franco received his medical degree from Santo Domingo University. He completed his internship at St. Alexis Hospital in Cleveland, Ohio and his residency at Cleveland Veterans Administration Hospital. Following his clinical training, Dr. Franco received fellowships in clinical cardiology and invasive cardiology from The Cleveland Clinic Foundation. He was appointed to the Cleveland Clinic in 1971.

Dr. Franco’s research has focused primarily on the safe and effective treatment of coronary artery disease, including studies of expandable stents, saphenous vein grafts and guided radio frequency energy ablation. He has published his research findings and his clinical experience in articles and abstracts in leading publications. Most recently, he co-authored an article on peripheral vascular disease, bare metal stenting, and long-term outcomes following coronary stenting.

He is a member of the American Medical Association, the American Heart Association (Northeast Ohio Affiliate), and the Ohio State Medical Association.

Diagnostic cardiac catheterization, angiography and interventional cardiology, coronary angioplasty, acute coronary interventions, coronary atherectomy, rotational coronary stenting, laser therapy.

• American Medical Association
• American Heart Association (Northeast Ohio Affiliate)
• Ohio State Medical Association

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/8/2008, Dr. Franco has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)